{"title":"Ntenga Syndrome: About an Observation","authors":"","doi":"10.33140/an.03.03.03","DOIUrl":null,"url":null,"abstract":"Ntenga syndrome, is one of the highly epileptogenic, non-metabolic craniopathy whose aetiology is not yet known. This syndrome makes a differential diagnosis with that of Morgagni-Stewart-Morel which is rare and / or rarely mentioned in current clinical practice (entity made of frontal hyperostosis, neuropsychiatric and endocrine disorders). We report here a 58 years old female patient from Lubumbashi/ Democratic republic of Congo, followed for several years for multiform seizures, in whom the explorations of a status epilepticus, made possible to set up a new syndromic entity, called Ntenga syndrome made of a symptomatic triad (persistent multiform epileptic seizures, absence of endocrine disorder, hyperostosis frontalis interna). To date, a therapeutic protocol made of valproic acid and levetiracetam has significantly reduced to one seizure per month or even every 2 months. I think it is not without interest to report a very rare and / or new entity in the clinic.","PeriodicalId":93246,"journal":{"name":"Advances in neurology and neuroscience","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in neurology and neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33140/an.03.03.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Ntenga syndrome, is one of the highly epileptogenic, non-metabolic craniopathy whose aetiology is not yet known. This syndrome makes a differential diagnosis with that of Morgagni-Stewart-Morel which is rare and / or rarely mentioned in current clinical practice (entity made of frontal hyperostosis, neuropsychiatric and endocrine disorders). We report here a 58 years old female patient from Lubumbashi/ Democratic republic of Congo, followed for several years for multiform seizures, in whom the explorations of a status epilepticus, made possible to set up a new syndromic entity, called Ntenga syndrome made of a symptomatic triad (persistent multiform epileptic seizures, absence of endocrine disorder, hyperostosis frontalis interna). To date, a therapeutic protocol made of valproic acid and levetiracetam has significantly reduced to one seizure per month or even every 2 months. I think it is not without interest to report a very rare and / or new entity in the clinic.
Ntenga综合征是一种高度致痫的非代谢性颅骨疾病,其病因尚不清楚。该综合征可与Morgagni Stewart Morel综合征进行鉴别诊断,后者在目前的临床实践中很罕见和/或很少提及(由额叶骨质增生、神经精神和内分泌障碍组成的实体)。我们在这里报道了一名来自刚果民主共和国卢本巴希的58岁女性患者,她因多种形式的癫痫发作进行了几年的随访,对其癫痫持续状态的探索使其能够建立一个新的综合征实体,称为Ntenga综合征,该综合征由一个症状三联征组成(持续的多种形式癫痫发作、没有内分泌紊乱、额肌内部骨质增生)。迄今为止,由丙戊酸和左乙拉西坦组成的治疗方案已显著减少到每月甚至每2个月发作一次。我认为,报告诊所中一个非常罕见和/或新的实体并非没有兴趣。